In HealthNewsReview.org, Susan Molchan reviews some of the latest research promoting the use of an ADHD drug to treat loss of executive functions in women during menopause — though, she writes, there’s little evidence that women experience loss of executive functions during menopause, or that this drug could help if they did.
“Women going through menopause also often have problems with sleep,” Molchan writes. “The last thing someone with anxiety and trouble sleeping needs is a stimulant. Nor do older women need a drug that can increase risk of heart arrhythmias, heart attack, and stroke. Nor one that risks abuse and dependence — this one not only has shades of diet drugs from the ‘50s and ‘60s; Vyvanse releases the same dextroamphetamine that was in one of the most popular, Dexedrine.”
Vyvanse – A life cycle drug? Or disease mongering? (HealthNewsReview.org, June 25, 2015)